Updated:
Unovis Asset Management
Dan Altschuler's Unovis Asset Management funds the companies reengineering global protein supply chains.
Unovis Asset Management
Unovis Asset Management is an SEC-registered investment adviser since 2020. It manages client assets. The firm is headquartered in New York.
General information
Firm type
Venture Capital
Year founded
2016
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Dan Altschuler
Managing Partner
Sector focus
Frequently asked questions
What is Unovis's investment mandate?
Unovis Asset Management invests exclusively in companies that are transforming the global protein supply chain. The firm targets three core technology verticals: plant-based protein innovation, precision fermentation, and cultivated meat and seafood production. Its mandate excludes generalist climate-tech, food-delivery, and conventional agriculture plays.
Who runs investment decisions at Unovis?
Dan Altschuler, who founded the firm in 2016, serves as Managing Partner and runs investment decisions. Prior to launching Unovis, Altschuler built a track record as an early institutional backer of alternative-protein companies, which positioned him to anchor the firm's thesis as the space began attracting mainstream venture attention.
Does Unovis participate in fund commitments or only direct deals?
Unovis invests primarily through direct equity positions in operating companies, spanning seed through growth-stage rounds. Based on the firm's observable co-investment patterns, it does not operate a fund-of-funds program but will syndicate deals alongside other sector-specialist investors and occasionally alongside sovereign-backed capital.
Which regions does Unovis back companies in?
The portfolio draws from innovation clusters in North America, Western Europe, and Israel — regions that have produced the majority of venture-scale alternative-protein startups. The firm has not disclosed dedicated emerging-market or Asia-Pacific allocations.
What is the Protein Directory, and how is it connected to Unovis?
The Protein Directory is a public-benefit data platform tracking alternative-protein company formation, funding rounds, and technology milestones globally. Unovis launched and maintains the directory, which functions simultaneously as an industry public good and as a sourcing tool that reinforces the firm's access to early-stage deal flow across the sector.
How does Unovis differ from generalist climate-tech or impact funds?
Unlike broad climate or impact funds that allocate small portions of capital to food-tech, Unovis is a single-mandate firm: every dollar it deploys goes toward protein-system transformation. This narrow focus gives it deeper scientific and supply-chain due-diligence capabilities in alternative proteins than a generalist platform can typically develop internally.
Has Unovis disclosed its AUM?
No. Unovis Asset Management has not publicly reported assets under management or aggregate deployment figures. The firm's fundraising posture remains private, consistent with many specialist venture managers operating below institutional reporting thresholds.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: